RBC keeps Outperform on Verisk after AccuLynx ruling
Alpha Vantage · Investing.com India · · AI-summarised by FinFlash
RBC Capital reiterated its Outperform rating and $230 price target on Verisk Analytics after the Delaware Supreme Court upheld a ruling that Verisk's termination of its $2.35 billion AccuLynx acquisition was invalid. Verisk must now pursue FTC approval and close the deal, which is expected to raise leverage and temporarily constrain share repurchases.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.